Should Tamoxifen Be Used in Breast Cancer Prevention?
- Published in:
- Drug Safety, 2004, v. 27, n. 13, p. 979, doi. 10.2165/00002018-200427130-00001
- By:
- Publication type:
- Article
Works matching IS 01145916 AND DT 2004 AND VI 27 AND IP 13
Results: 6
1
2
Use of Selective Serotonin Reuptake Inhibitors in Children and Adolescents.
- Published in:
- Drug Safety, 2004, v. 27, n. 13, p. 991, doi. 10.2165/00002018-200427130-00002
- By:
- Publication type:
- Article
3
Safety of a New Oral Contraceptive Containing Drospirenone.
- Published in:
- Drug Safety, 2004, v. 27, n. 13, p. 1001, doi. 10.2165/00002018-200427130-00003
- By:
- Publication type:
- Article
4
Treatment Costs to Prevent or Treat Upper Gastrointestinal Adverse Events Associated with NSAIDs: A Review.
- Published in:
- Drug Safety, 2004, v. 27, n. 13, p. 1019, doi. 10.2165/00002018-200427130-00004
- By:
- Publication type:
- Article
5
Benefit-risk assessment of tolterodine in the treatment of overactive bladder in adults.
- Published in:
- 2004
- By:
- Publication type:
- journal article
6
The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients.
- Published in:
- 2004
- By:
- Publication type:
- journal article